Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

Fig. 4

Volcano plots demonstrating different miRNA expression levels in whole blood in two-group comparisons. Volcano plots showing the log2 fold differences of the average miRNA expression in whole blood on the x-axis and the negative decade logarithm of the unadjusted p value on the y-axis. a Patients with NMOSD vs. patients with CIS/RRMS, b patients with NMOSD vs. healthy controls, c patients with CIS/RRMS vs. healthy controls. The horizontal lines indicate a p value of 10−3. CIS clinically isolated syndrome, RRMS relapsing-remitting multiple sclerosis, NMOSD neuromyelitis optica spectrum disorder

Back to article page